The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)
We describe the cautionary case of a patient with advanced-stage large B-cell lymphoma (DLBCL). After combination chemotherapy, CT-PET revealed a persistent focus of likely DLBCL for which he received radiotherapy. Follow-up CT-PET showed diffuse hypermetabolic adenopathy and recurrent DLBCL was pre...
Main Authors: | Peter D. Whooley, Russell K. Dorer, David M. Aboulafia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048918300062 |
Similar Items
-
Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
by: Wenqi Zhang, et al.
Published: (2021-01-01) -
The regulatory mechanism of cell death by rigosertib in diffuse large B-cell lymphoma (DLBCL)
by: Yi-HanDai, et al.
Published: (2015) -
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
by: Pengcheng Feng, et al.
Published: (2021-02-01) -
Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)
by: Roba M. Talaat, et al.
Published: (2014-01-01) -
Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
by: Gleeson Michelle, et al.
Published: (2010-11-01)